CDKN2A and breast cancer: Dulaimi et al. reported the hypermethylation of APC, RASSF1A or CDKN2A (p14ARF) in urine ctDNA from 39 out of 45 BC patients (87% sensitivity and 100% specificity), even detecting 16 cases that showed a negative result in cytology assays [111].